VA sole-source Oncotype DX cancer testing services.
Some language patterns suggest this RFP may be written for a specific incumbent vendor. Review qualification requirements and brand-specific terms carefully before committing bid resources.
The Department of Veterans Affairs, Network Contract Office 21, intends to award a sole-source contract to Exact Sciences Corporation for Oncotype DX genomic cancer assay testing services. These tests are used to guide treatment decisions for breast, colon, and prostate cancers. The requirement is for the Mather, CA VA medical center. Only Exact Sciences holds the proprietary rights to the Oncotype DX test, making this a sole-source procurement. No competitive solicitation will be issued.